Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

118
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
118
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Triangular Interaction Between Dietary Polyphenols, Gut Microbiota and Type 2 Diabetes.

International journal of molecular sciences·2026
Same author

Correction: Luo et al. Dietary Anti-Aging Polyphenols and Potential Mechanisms. <i>Antioxidants</i> 2021, <i>10</i>, 283.

Antioxidants (Basel, Switzerland)·2026
Same author

Type 3 Diabetes: Linking Insulin Resistance to Cognitive Decline.

Diseases (Basel, Switzerland)·2025
Same author

The Impact of Active Augmented Reality Games on Physical Activity and Cognition Among Older Adults: Feasibility Study.

JMIR serious games·2025
Same author

Acetaminophen's Role in Autism and ADHD: A Mitochondrial Perspective.

International journal of molecular sciences·2025
Same author

Embryonic Thermal Programming and Dietary Baicalein Supplementation Post-Hatch: Effects on Broiler Adipose Tissue Deposition.

Animals : an open access journal from MDPI·2025

Related Experiment Video

Updated: Jun 13, 2025

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
11:44

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Published on: January 19, 2022

2.5K

Potential Application of Plant-Derived Compounds in Multiple Sclerosis Management.

Seth Woodfin1, Sierra Hall1, Alexis Ramerth1

  • 1Department of Biology and Chemistry, School of Health Sciences, Liberty University, Lynchburg, VA 24515, USA.

Nutrients
|September 14, 2024
PubMed
Summary

Plant compounds show promise for treating multiple sclerosis (MS). These natural substances may reduce inflammation and aid nerve repair, offering new hope beyond current therapies for MS patients.

Keywords:
alkaloidscatecholinflammationmultiple sclerosisplant-derived compoundspolyphenolsterpenoids

More Related Videos

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.2K
Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
10:44

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

10.2K

Related Experiment Videos

Last Updated: Jun 13, 2025

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
11:44

Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B

Published on: January 19, 2022

2.5K
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.2K
Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord
10:44

Two-photon Imaging of Cellular Dynamics in the Mouse Spinal Cord

Published on: February 22, 2015

10.2K

Area of Science:

  • Neuroimmunology
  • Pharmacology
  • Natural Products Chemistry

Background:

  • Multiple sclerosis (MS) is a chronic autoimmune disease causing inflammation, demyelination, and neurodegeneration.
  • Current MS treatments focus on immune regulation but have limitations in efficacy and tolerability.
  • There is a need for novel therapeutic strategies to manage MS progression and improve patient quality of life.

Purpose of the Study:

  • To review the pathogenesis of MS, focusing on the role of inflammation.
  • To evaluate the potential of plant-derived compounds as adjunctive therapies for MS.
  • To detail the mechanisms of action and clinical potential of these compounds for MS.

Main Methods:

  • Literature review of preclinical and clinical studies on plant-derived compounds and MS.
  • Analysis of molecular and cellular mechanisms underlying MS pathogenesis.
  • Assessment of anti-inflammatory and neuroprotective properties of plant compounds.

Main Results:

  • Plant-derived compounds (alkaloids, phenylpropanoids, terpenoids) exhibit significant anti-inflammatory effects.
  • These compounds can modulate immune responses relevant to MS.
  • Evidence suggests potential for neuroregeneration and symptom attenuation in MS.

Conclusions:

  • Plant-derived compounds represent a promising avenue for novel adjunctive therapies in multiple sclerosis.
  • Their anti-inflammatory and neuroprotective properties warrant further investigation for MS treatment.
  • These natural compounds may offer a valuable addition to current therapeutic approaches for MS.